. . . "it is worth noting the nuance in the academy's stance: it says that while banking as biological insurance for the newly born infant is unwise, it should be considered if a sibling has a condition such as leukemia or a genetic disorder that may be cured with a stem cell transplant, as it is likely that the cord blood from a brother or sister will be a closer match than one from an unrelated donor." . .